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Craniosynostosis is the premature fusion of the cranial vault sutures. We have previously described a colony of rabbits with a
heritable pattern of nonsyndromic, coronal suture synostosis; however, the underlying genetic defect remains unknown. We now
report a molecular analysis to determine if four genes implicated in human craniosynostosis, TWIST1 and fibroblast growth factor
receptors 1–3 (FGFR1–3), could be the loci of the causative mutation in this unique rabbit model. Single nucleotide polymorphisms
(SNPs) were identified within the Twist1, FGFR1, and FGFR2 genes, and the allelic patterns of these silent mutations were examined
in 22 craniosynostotic rabbits. SNP analysis of the Twist1, FGFR1, and FGFR2 genes indicated that none were the locus of origin
of the craniosynostotic phenotype. In addition, no structural mutations were identified by direct sequence analysis of Twist1 and
FGFR3 cDNAs. These data indicate that the causative locus for heritable craniosynostosis in this rabbit model is not within the
Twist1, FGFR1, and FGFR2 genes. Although a locus in intronic or flanking sequences of FGFR3 remains possible, no direct structural
mutation was identified for FGFR3.
1. Introduction
Craniosynostosis (CS) is the premature fusion of one ormore
of the fibrous joints of the calvaria (cranial sutures). If this
synostosis happens early enough in human development,
it can lead to alterations in skull shape, reduced cranial
growth, increased intracranial pressure, impaired blood flow,
impaired vision and hearing, as well as mental retardation
[1–7]. In most cases, surgical intervention is necessary to
improve the patient’s prognosis [8–11]. There are extensive
signaling networks present within the cranial sutures that
allow for the coordinated growth of the skull [12]. One
such network involves the fibroblast growth factor receptors
(FGFRs). FGFRs belong to a family of tyrosine kinase
receptors that exhibit a common organization, including
two or three extracellular immunoglobulin (Ig) like binding
domains, a transmembrane domain, and two intracellular
tyrosine kinase subdomains [13]. The binding of FGF to
FGFR in association with heparin sulphate proteoglycan
(HSPG) induces receptor dimerization at the cell surface.
This dimerization in turn leads to autophosphorylation that
triggers phosphorylation of downstream signaling proteins
[13]. In calvarial sutures, FGFs are secreted by osteoblasts
at the differentiated edge of the bones; they activate recep-
tors involved in both osteoprogenitor cell proliferation and
function in the conversion of these cells into differentiated
osteoblasts [12, 14–22]. Once the FGFR signaling system is
established in sutures, long-term skull growth depends on the
maintenance and balance between the formation of new bone
and the proliferation of the osteoprogenitor cell population as
a reservoir of potential new osteoblasts [2, 12].
Genetic mutations in the fibroblast growth factor recep-
tors (FGFR1–3) are some of the most commonly identified
mutations implicated in syndromic craniosynostosis [23–32].
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Most of these mutations are autosomal dominant, gain-of-
function mutations.The amplified signaling that results from
these mutations plays an important role in the overossi-
fication at the site of sutures [2, 12, 21]. In addition to
the FGFR signaling mutations, TWIST1 is implicated in
craniosynostosis in humans with Saethre-Chotzen syndrome
[33–36]. Mutations within TWIST1, a basic-helix-loop-helix
transcription factor, result in TWIST1 haploinsufficiency,
presenting as unilateral or bilateral coronal suture fusion
among other facial malformations in patients with cran-
iosynostosis [1, 33–35, 37]. TWIST1 is known to function
as a regulator of mesenchymal lineage specification during
skeletal development including within the cranial vault [37].
Twist1 heterozygous knockoutmice have been shown to reca-
pitulate the craniosynostosis phenotype of Saethre-Chotzen
syndrome [38].
Previously, we have described a rabbit model with con-
genital nonsyndromic craniosynostosis of the coronal suture
[39–44]. Similar to humans, this colony of affected New
Zealand White rabbits demonstrates autosomal dominant
transmission with variable phenotypic expression [39]. The
animals present with a broad range of phenotypes for the
isolated coronal suture synostosis pathology, including uni-
laterally or bilaterally affected animals that exhibit suture
fusion at birth or with delayed-onset synostosis [41–44]. The
genetic defect within this rabbit model is unknown, and a
lack of molecular tools in rabbits has thus far made mapping
genetic defects problematic. Herein, we conducted a molec-
ular analysis of the rabbit colony to determine the cDNA
coding sequence of Twist1 and the full-length sequence
of FGFR3 (as the rabbit sequences of these genes were
previously unknown). We used SNP analysis to determine
whether FGFR1, FGFR2, or Twist1 were associated with the
craniosynostosis phenotype of the rabbit colony.
2. Materials and Methods
2.1. Animals. All animal protocols were reviewed and
approved by the Institutional Animal Care and Use Com-
mittee (IACUC). Animals were diagnosed and surgeries
performed as previously described [45]. A 5mm ear punch
biopsy was obtained from 22CS rabbits postmortem; the
resulting biopsies were stored in RNAlater (Ambion, Austin,
TX, USA) for use in genomic DNA extractions.
2.2. RNA Extraction/Purification of Samples/Preparation of
cDNAs. For all WT and CS tissue RNA purifications, total
RNA was purified from perisutural calvarial tissue of 10-
day-old rabbits using the RNeasy Mini Kit (Qiagen Inc.,
Valencia, CA, USA) following manufacturer protocols after
homogenization using a homogenizer and an on-column
DNase treatment step as previously described [45]. Quality of
RNA extracted was determined by capillary electrophoresis
using an Agilent (Santa Clara, CA, USA) 2100 Bioanalyzer as
previously described [45].
RNA from 2WT and 2CS rabbits was individually
subjected to reverse transcription using SMARTScribe RT
(Clontech, Mountain View, CA, USA) following manufac-
turer’s protocol and utilizing the GeneRacer oligo dT reverse
primer (Invitrogen, Carlsbad, CA, USA) and SMARTer II
oligo (Clontech) for reverse transcription of all cDNAs for
cloning.
2.3. Identification of Rabbit FGFR3/Twist1 cDNA Sequences.
To determine rabbit sequence for FGFR3 and Twist1,
primers were initially designed based on the predicted
coding sequence for FGFR3 in Ochotona princeps
(ENSOPRG00000002205) from Ensembl (http://www.en-
sembl.org/) and using human TWIST1 from Ensembl
(ENST00000242261). For FGFR3, Ochotona princeps
(American Pika) was chosen as it is a closely related mammal
to rabbit. Various primer sets were designed using Vector
NTI (Invitrogen) to amplify the FGFR3 rabbit cDNAs in a
stepwisemanner based on sequence similarity with FGFR3 in
Ochotona princeps. Using these sequence fragments, a full-
length rabbit cDNA sequence was determined from one WT
rabbit RNA sample (data not shown). This sequence is given
as Supplemental Figure 3 of the Supplementary Material
available online at http://dx.doi.org/10.1155/2013/305971 and
was used as a baseline to determine whether FGFR3 was
structurally mutated in the CS animals.
Primers T1-1 and T1-2, matching human TWIST1, were
used to amplify the rabbit coding sequence of Twist1 from
one WT rabbit. PCR was done using the AccuPrime HF
system with buffer no. 1 (Invitrogen) supplemented with 2X
PCRx Enhancer (Invitrogen), using the following cycling
parameters: 95∘C for 2 minutes, 43 cycles of 95∘C for 25
seconds, 62.5∘C for 30 seconds, 68∘C for 1 minutes, on
an MJ Tetrad cycler (Bio-Rad, Hercules, CA, USA). PCR
reactions were separated on 1% TAE agarose gels, and the
resulting primary amplicon of ∼600 bp was gel extracted
and sequenced. The rabbit Twist1 coding region consisted of
627 bp, and an alignment of human to rabbit Twist1 is given
as Supplemental Figure 1.
2.4. Amplification of the FGFR3 cDNA Coding Region. Pre-
pared cDNAs from WT and CS animals were used to clone
FGFR3 in three steps; first, the majority of the coding
region plus the 3󸀠 UTR were obtained using primers F3–1
and F3-2. 5󸀠 RACE was performed utilizing the SMARTer
PCR cDNA synthesis system following the manufacturer
instructions (Clontech). Clones consisting of the 5󸀠 UTR and
an overlapping part of the coding sequence were obtained
first using primers F3-3 with the Clontech Universal Primer
Mix. Clones consisting of the terminal 3󸀠 UTR were obtained
using primers F3–5 with the GeneRacer 3R Primer. Nested
PCR was performed to enrich for 5󸀠 and 3󸀠 UTR target
specific PCR products using 1 𝜇L purified PCR aliquot from
the first round of PCR, the Clontech nested 5󸀠 primer or
GeneRacer Nested 3󸀠 primer, and primer F3-4 (5󸀠 UTR)
or primer F3–6 (3󸀠 UTR). All PCRs were done using the
AccuPrime HF system with buffer no. 1 (Invitrogen). PCR
reactions were separated on 0.8% TAE agarose gels, and the
resulting primary amplicons were gel extracted following
standard protocols (QIAquick Spin kit, Qiagen).
The resulting cDNA PCR amplimers were subcloned into
the pCR4 vector with TOPO-mediated cloning and trans-
formed into TOP10 cells by electroporation as previously
International Journal of Genomics 3
described [33]. Eight clones were selected for each rabbit
cDNA; cloned vectors were propagated and miniprepped as
previously described [33]. Plasmids were sequenced using
M13 forward, M13 reverse, and various custom primers
on an Applied Biosystems (Foster City, CA, USA) 3730xl
DNA Analyzer using standard methods. All sequences were
compared to the identified rabbit sequence for FGFR3 using
the basic local alignment search tool “BLAST” program
(http://www.ncbi.nlm.nih.gov/BLAST/).
2.5. Genotyping SNPs for FGFR1, FGFR2, and Twist1. Ge-
nomic DNA from CS ear punch biopsies was purified using
the tissue lysis protocol for the DNeasy genomic DNA purifi-
cation system (Qiagen). Genomic DNA was eluted in AE
buffer and quantified using an ND-1000 spectrophotometer
(NanoDrop Technologies, Inc., Wilmington, Del, USA).
To identify single nucleotide polymorphisms, we
first designed primers using Vector NTI (Invitrogen)
based on the predicted coding sequence for FGFR1
in rabbit (ENSOPRG00000002205) from Ensembl
(http://www.ensembl.org/) and the published rabbit FGFR2
sequence from NCBI (http://www.ncbi.nlm.nih.gov/) [46].
Genomic PCR was performed using the AccuPrime HF
system with buffer no. 2 (Invitrogen) and Platinum Taq
Polymerase using primers F1-e9-SNPF and F1-e9-SNPR
(FGFR1) and F2-SNPF and F2-SNPR (FGFR2); 5% DMSO
(final concentration) was added to FGFR1 genotyping
reactions. The following cycling parameters were used for
genomic DNA amplification: 95∘C for 2 minutes, 45 cycles
of 95∘C for 30 seconds, 58.7∘C for 30 seconds, 68∘C for 1.5
minutes, on an MJ Tetrad cycler (Bio-Rad); 61∘C annealing
temperature was used for FGFR1 instead of 58.7∘C. PCR
reactions were originally examined on a 1% TAE agarose
gel, yielding single amplicons of 1472 bp (FGFR1) and
930 bp (FGFR2). PCR reactions were purified using the
Nucleospin96 system following the manufacturer’s protocol
(Macherey-Nagel, Inc., Bethlehem, Pa, USA) with elution
in 30 𝜇L 5mM Tris, pH 8.5. Purified PCR products were
directly sequenced with the sequencing primers F1-e9-SNP-
seqF (FGFR1) or F2-SNP-seqF (FGFR2) on an Applied
Biosystems (Foster City, CA, USA) 3730xl DNA Analyzer
using standard methods. Resulting sequencing data were
aligned in Sequencher (Gene Codes Corp., Ann Arbor, MI,
USA) to identify SNPs.
Several single nucleotide polymorphisms (SNPs) were
identified while obtaining the rabbit coding sequence
for Twist1. Genomic PCR was performed utilizing the
AccuPrime HF system with buffer no. 2 (Invitrogen), PCRx
Enhancer (Invitrogen, 2 X final concentration), and Platinum
Taq Polymerase using primers T1-1 and T1-2 (Table 1). The
following cycling parameters were used for genomic DNA
amplification: 95∘C for 2 minutes, 45 cycles of 95∘C for 30
seconds, 64∘C for 30 seconds, 68∘C for 1.5 minutes, on an
MJ tetrad cycler (Bio-Rad). PCR reactions were originally
verified on a 1% TAE agarose gel, yielding single amplicons
of 627 bp (Twist1). PCR reactions were purified using the
Nucleospin96 system following the manufacturer’s protocol
(Macherey-Nagel, Inc., Bethlehem, Pa, USA) with elution
in 30 𝜇L 5mM Tris, pH 8.5. Purified PCR products were
directly sequenced utilizing standard sequencing conditions
with the sequencing primer T1-SNP-seqF (Table 1). Resulting
sequencing data were aligned in Sequencher (Gene Codes
Corp., Ann Arbor, MI, USA) to identify SNPs.
3. Results
Ourmain objective was to determine whether Twist1, FGFR1,
FGFR2, or FGFR3 were the sites of causative mutation within
our rabbit model of craniosynostosis. Because the Twist1
sequence in rabbit was unavailable, we initially cloned and
sequenced the coding portion of the cDNA for Twist1 from
a WT rabbit, obtaining novel Twist1 coding DNA sequence.
The structural coding sequence of rabbit Twist1 cDNA is
627 bp long as compared to the 609 bp TWIST1 coding
sequence in humans (NCBI, NM 000474); Supplemental
Figures 1 and 2 present the alignments of the Twist1 cDNA
and protein homologs. Although we did not clone the
full cDNA sequence, we identified several SNPs within the
rabbit Twist1 cDNA sequence that made full sequencing
unnecessary for our purposes, as described below. All of the
identified SNPs were silent mutations.
The rabbit sequence for FGFR1 was available from
Ensembl, and we previously published the rabbit sequence
for FGFR2 [46]. However, to address FGFR3, we initially
cloned and sequenced the entire cDNA for FGFR3 from
WT rabbit RNA template, obtaining novel full-length FGFR3
cDNA sequence including 5󸀠 and 3󸀠 UTR sequences. Using
the identified FGFR3 cDNA sequence, we purified RNA from
calvariae of 10-day-old rabbits, using two WT and two CS
rabbits, and we cloned and sequenced FGFR3 from at least
eight different clones in three steps as described in Section 2
(Figure 1).The sequences obtainedmatched the rabbit coding
sequence we originally identified for WT FGFR3. Rabbit
FGFR3 was determined to be 3684 bp long, resulting in a
predicted protein of 802 amino acids, as compared to the
4304 bp FGFR3 sequence in humans (NCBI, NM 000142.4)
that results in a predicted protein of 806 amino acids; Sup-
plemental Figures 3 and 4 consist of alignments between the
FGFR3 cDNA and protein homologs. Multiple isoforms of
FGFR3 are known in humans, and several were identified
in our rabbit samples as well, including two different 5󸀠
UTRs and two different 3󸀠 UTRs. However, there were no
differences observed between the WT and CS animals in the
types of isoforms present or in their sequences.
Although no structural mutation within the coding
sequence had been identified, we sought tomore conclusively
rule out the involvement of Twist1 within our rabbit model of
craniosynostosis aswell.We identified silent single nucleotide
mutations within the coding sequence for Twist1 while
cloning the rabbit Twist1 cDNA. SNP analysis on genomic
DNA from 22CS animals was then performed by sequencing
PCR amplimers using primers flanking the chosen SNP. The
SNP was identified as a variation within our animals of C/C,
T/T, or C/T (Figures 2(a)–2(c)). Results of sequencing our 22
animals are reported in Figure 2(d); six animals were C/C,
three animals were T/T, while 13 animals were C/T. These
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Table 1: Primers used in this study.
Primer sequence
FGFR1 primers
F1-e9-SNPF F TGAAACCAAACAGCCACCTACTG
F1-e9-SNPR R CGAAGACAGGACGACGATGAAAAC
F1-e9-SNP-seqF F TGGTGACGGGTCGTAAC
FGFR2 primers
F2-SNPF F CCAGCCCATTTTTCACCGAAC
F2-SNPR R GAATCTCACTCCCACTGACATCATC
F2-SNP-seqF F GTCGTCAAGTGGTTATCCC
Twist1 primers
T1-1 F ATGATGCAGGACGTGTCCA
T1-2 R CTAGTGGGACGCGGACATG
T1-SNP-seqF F ACGACAGCCTGAGCAACAG
FGFR3 primers
F3–1 F CGACAGGAACAGGTGGTCTTTGG
F3-2 R CGGCACAGGCAGCAATTAAAG
F3-3 R CCACCTTGCTGCCGTTCACCTC
F3-4 R TCCACTGCTGGTGCCGCAGCTTG
F3–5 F GACGACTCCGTGTTCACCC
F3–6 F GGAGGGGACCAGAAGTAGAATGTAG
Translation 
Translation 
start stopFGFR3 (3684
bp cDNA 
clone) F3-2
F3–6F3–5F3-4F3-3
F3–1
Figure 1: No structural mutations in FGFR3 in CS rabbits. Schematic depiction of FGFR3, with locations of primers employed. Full-length
rabbit clones for FGFR3 were 3684 bp, as compared to approximately 4300 bp in human FGFR3.
data indicated that it is extremely unlikely that Twist1 is the
etiological locus of our craniosynostotic phenotype.
We next sought to similarly determine whether FGFR
loci were linked to the inherited craniosynostosis observed
in our colony by using independent assortment of SNPs. We
sequenced across exons 8 and 9 within FGFR1, including
the splice sites flanking both exons. Amplified PCR products
from genomic DNA obtained from 22 randomly selected yet
related CS animals from the craniosynostotic colony made
up our test group. There were no mutations within the exons
(data not shown), but we identified a mutation within intron
8. This SNP was originally reported as “G” at Ensembl, while
our animals variously carry G/G, A/A, or G/A (Figures 3(a)–
3(c)). Results of sequencing our 22CS animals are reported
in Figure 3(d); nine animals were G/G, six animals were A/A,
and seven animals wereG/A.Thus, neither the “G” nor the “A”
allele cosegregatedwith the disease phenotype, and a plurality
of affected animals actually shared theG/G genotype found in
wild type rabbit sequence as reported in Ensembl.
For FGFR2, after sequencing across exon 9 including
the flanking splice sites, we identified an SNP, a structurally
silent mutation, within the coding sequence. This SNP was
originally reported as “G” at NCBI, while our animals display
G/G, A/A, or G/A (Figures 4(a)–4(c)). Results of sequencing
from our 22CS animals are reported in Figure 4(d); five
animals wereG/G genotype, seven animals wereA/A, and ten
animals were G/A. As with FGFR1, neither the “G” nor the
“A” allele cosegregates with the affected phenotype, rendering
it extremely unlikely that this locus is the site of causative
mutation.
4. Discussion
TWIST1 mutations were some of the first genetic defects
linked to craniosynostosis in humans [27–29]. In addition,
mutations within FGFR1–3 are known to cause craniosynos-
tosis in humans [1–3, 15].The sequences of FGFR3 and Twist1
(mRNA and gene) were previously unknown in rabbits.
We have now determined the sequence of FGFR3 cDNA
in the rabbit and determined that no structural mutations
are present to explain the craniosynostotic phenotype, such
as the P250R mutation commonly observed in Muenke
syndrome [25]. We did identify several splice variants within
FGFR3, including transcripts containing and lacking the
“VT” amino acid insertion at the end of exon 10; however,
these have been previously studied in other animals and
in other FGFRs and were present within both WT and CS
populations [47–49]. All splice variants obtainedwould result
in the same predicted protein of 802 amino acids (or 804
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AAGAAGTCTGCGGGCTGCGGCGGTGGCGGCGGCGGCGGTGGTGGCGGCG
∗
160 170 180 190 200
(a)
AAGAAGTCTGCGGGCTGCGGCGGTGGTGGCGGCGGCGGTGGTGGCGGCG
160 170 180 190 200
(b)
AAGAAGTCTGCGGGCTGCGGCGGTGGYGGCGGCGGCGGTGGTGGCGGCG
∗
160 170 180 190 200
(c)
Animal Penetrance Twist1 (WT C/C)
CS3520 Right unilateral
Right unilateral
C/T
C/T
C/T
C/T
C/C
C/C
C/C
C/C
C/C
C/C
CS4405
CS3733 Left unilateral
Left unilateral
Left unilateral
Left unilateral
CS3785
CS4484
CS3687
CS4160 Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
T/T
T/T
CS4075 T/T
CS3982 C/T
C/T
C/T
C/T
C/T
C/T
C/T
C/T
C/T
CS3871
CS4072
CS4097
CS3777
CS3737
CS4050
CS3524
CS3699
CS4439
CS4568 Delayed, bilateral
CS4569
CS4570 Delayed
Delayed
Delayed
DelayedCS4572
(d)
Figure 2: SNP discovery and genotyping of Twist1 in craniosynostotic rabbits. We identified a SNP within the Twist1 coding region, a silent
mutation, that segregates independently of craniosynostosis within our colony, ruling out Twist1 as the causative agent. ((a)–(c)) Sequencing
traces representing C/C (a), T/T (b), or C/T (c) genotypes from PCR using CS genomic DNA. (d) Results of sequencing 22 randomly selected
CS animals; six animals were C/C genotype, three animals were T/T, and 13 animals were C/T.
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540530520510500
ACCCCTAAATGAGGCAGAGGAGATGGGTGTTGTTTTTCTAATGCAGTGG
∗
(a)
540530520510500
ACCCCTAAATGAGGCAGAGGAGATAGGTGTTGTTTTTCTAATGCAGTGG
∗
(b)
530520510500
∗
ACCCCTAAATGAGGCAGAGGAGATRGGTGTTGTTTTTCTAATGCAGTGG
540
(c)
Animal Penetrance FGFR1 (WT G/G)
CS3520 Right unilateral
Right unilateral
G/A
G/G
G/A
G/G
G/A
G/A
G/A
G/A
G/A
G/G
G/G
G/G
G/G
G/G
G/G
G/G
CS4405
CS3733 Left unilateral
Left unilateral
Left unilateral
Left unilateral
CS3785
CS4484
CS3687
CS4160 Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
A/A
A/A
A/A
A/A
A/A
A/A
CS4075
CS3982
CS3871
CS4072
CS4097
CS3777
CS3737
CS4050
CS3524
CS3699
CS4439
CS4568 Delayed, bilateral
CS4569
CS4570 Delayed
Delayed
Delayed
DelayedCS4572
(d)
Figure 3: SNP discovery and genotyping of FGFR1 in craniosynostotic rabbits. We identified a FGFR1 SNP within intron 8 that segregates
independently of craniosynostosis within our colony, ruling out FGFR1 as the causative agent. ((a)–(c)) Sequencing traces representing G/G
(a), A/A (b), or G/A (c) genotypes from CS genomic DNA. (d) Results of sequencing of 22 randomly selected CS animals; nine animals were
G/G, six animals were A/A, and seven animals were G/A.
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GCAAAGGCCTCCGATGGTTTTCGTTTTGGTCCGCGGCTCGCTTCTGCCC
∗
130 140 150 160 170
(a)
GCAAAGGCCTCCGATGGTTTTCATTTTGGTCCGCGGCTCGCTTCTGCCC
∗
130 140 150 160 170
(b)
∗
130 140 150 160 170
GCAAAGGCCTCCGATGGTTTTCRTTTTGGTCCGCGGCTCGCTTCTGCCC
(c)
Animal Penetrance FGFR2 (WT G/G)
CS3520 Right unilateral
Right unilateral
G/A
G/G
A/A
A/G
G/A
G/G
G/A
G/A
G/G
A/A
G/A
G/A
G/A
G/G
G/A
G/G
CS4405
CS3733 Left unilateral
Left unilateral
Left unilateral
Left unilateral
CS3785
CS4484
CS3687
CS4160 Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
Complete
A/A
A/A
G/A
A/A
G/A
A/A
CS4075
CS3982
CS3871
CS4072
CS4097
CS3777
CS3737
CS4050
CS3524
CS3699
CS4439
CS4568 Delayed, bilateral
CS4569
CS4570 Delayed
Delayed
Delayed
DelayedCS4572
(d)
Figure 4: SNP discovery and genotyping of FGFR2 in craniosynostotic rabbits.We identified a FGFR2 SNP within exon 9, a silent mutation,
that segregates independently of craniosynostosis within our colony, ruling out FGFR2 as the causative agent. ((a)–(c)) Sequencing traces
representing G/G (a), A/A (b), or G/A (c) genotypes from CS genomic DNA. (d) Results of sequencing of 22 randomly selected CS animals;
five animals were G/G genotype, seven animals were A/A, and ten animals were G/A.
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if containing the additional “VT” amino acids described
above). Also identified were two different 5󸀠 UTRs and two
different 3󸀠 UTRs; however, these variants were also present
in both WT and CS animals. These variants comprised a
minor subset of the transcripts detected. The predominant
transcript of FGFR3 corresponded to the full-length clone
presented and was identical betweenWT andCS animals. No
mutations were detected exclusively in CS FGFR3 transcripts.
In addition, we have determined the Twist1 coding sequence
in rabbit. Our oneWT rabbit contained only the 627 bp form
of Twist1, as did all mutant animals tested. Previously, it has
been reported in humans that the glycine tract of TWIST1
in humans can have various numbers of polyglycine repeats
[50]. It is possible that these rabbits may also have a variable
number of polyglycine repeats, but we did not specifically
examine for this, as our SNP analysis of Twist1 had already
ruled it out as the causative locus.
Extensive studies within this rabbit colony have shown
that the CS phenotype is inherited in an autosomal dominant
manner [51]. We used genomic DNA obtained from inbred,
randomly selected CS rabbits to determine whether the SNPs
we identified in FGFR1, FGFR2, and Twist1 were linked to
the presence of craniosynostosis. Our data show that the
identified SNPs in FGFR1, FGFR2, and Twist1 all segregated
independently of the craniosynostotic phenotype, and there-
fore a mutation within these genes is highly unlikely to be the
causative agent of the craniosynostosis within our model. In
addition, independent analysis of FGFR2 within this colony
identified another SNP that also failed to segregate with
the craniosynostotic phenotype (data not shown), further
supporting our results.
These genes play roles in numerous syndromes that
involve craniosynostosis, including Apert, Crouzon, Pfeiffer,
and Jackson-Weiss syndromes [23–32], but each of these
syndromes contains multiple malformations in addition to
fusion of cranial sutures. This rabbit colony, however, does
not present with syndromic craniosynostosis but rather
simple craniosynostosis, with isolated fusion of primarily the
coronal suture(s). Previously we have reported that animals
have been identified within the colony that exhibit fusion
of the metopic suture; however, we believe that these fusion
events are likely the result of a multifactorial process and
these animals exhibit 100% mortality [52]. Therefore, our
studies described herein focused on the molecular character-
ization of rabbits containing confirmed phenotypes of either
wild type or coronal simple craniosynostosis. We previously
reported that FGFR2 did not have any mutations detected
across the coding sequence within these animals including
the mutations that have been observed in human syndromes
[46]. The current study indicates that this rabbit model of
nonsyndromic craniosynostosis likely does not devolve from
any other mutation outside of the FGFR2 coding region and
extends this same conclusion to FGFR1 and Twist1.
In conclusion, we sought to determine whether either
FGFR1–FGFR3 or Twist1 was the locus of the defect result-
ing in our rabbit heritable model of craniosynostosis. We
provide novel rabbit FGFR3 and Twist1 sequence data and
detected no obvious mutations comparing WT and mutant
animals; through SNP analysis, we also eliminate FGFR1,
FGFR2, and Twist1 as the etiological source of our defect.
This is not surprising as most mutations in humans that
cause craniosynostosis (including mutations in FGFR1–3
and TWIST1) tend to occur in syndromic cases of cran-
iosynostosis, although some reports have described clinical
cases where mutations in FGFR3 or TWIST1 are identified
in nonsyndromic craniosynostosis [53]. We have recently
determined that Tgf𝛽 receptors 1 and 2 are also unlikely
to be the loci of origin in this rabbit model of craniosyn-
ostosis [54]. In addition, using SNP analysis, MSX2 does
not appear to be the causative agent of craniosynostosis
in these rabbits [55]; this was expected as gain-of-function
mutations in MSX2 were identified primarily in one family
and result in Boston type craniosynostosis in humans [56].
This suggests that these animals may contain a mutation of
an as yet unknown effector of one of the major pathways
involved in craniosynostosis, which may possibly shed light
on the 85% of human craniosynostosis that are currently
of an unknown origin. Of recent interest, TCF12 has been
implicated in humannonsyndromic craniosynostosis, andwe
intend to investigate its role in this colony as well [57]. Work
within this rabbit model has thus far been hampered due
to the lack of readily available molecular tools in the rabbit.
Recent advances in next generation sequencingmay provide a
method to rapidly genotype animals where detailed genomic
data does not yet exist, providing an avenue to identify the
etiology of craniosynostosis in these animals [58].
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